Lv1
40 积分 2023-10-11 加入
Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3–Targeted Single-Domain Antibody PET
10天前
已完结
Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer
23天前
已关闭
Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization
2个月前
已完结
Glypican-3-Targeted PET Imaging for Precise Diagnosis of Hepatocellular Carcinoma: From Bench to Bedside
4个月前
已完结
皖公网安备34019202002308
